← Back to Patent Explorer
US4369175A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them

Assignee: Novartis Corp
•
Filing: 1981-07-27
•
Granted: 1983-01-18
•
Expires: 2001-07-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to a process for the manufacture of prolonged action and stable vincamine preparations, which process comprises reacting an acid addition salt of vincamine with an alkali metal salt or alkaline earth metal salt of a sulfonic acid cation exchange resin, in particular an alkali metal salt of a sulfonated copolymer of styrene with a small amount of divinyl benzene, in a polar reaction medium such as water. The invention further relates to the vincamine preparations so obtained, to the use thereof for the manufacture of ready-for-use medicaments for oral administration and to these medicaments themselves.

Inventors

  • 👤 Satish C. Khanna

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 23:16
CPC Classifications
C; C07; C07D; C07D461/00; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/58; A61K47/585

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 44 words
A process for the manufacture of prolonged action and stable vincamine resinates, which process comprises reacting an acid addition salt of vincamine with an alkali metal salt or alkaline earth metal salt of a sulfonic acid cation exchange resin, in a polar reaction medium.
Claim 2
Dependent Claim 44 words
A process for the manufacture of prolonged action and stable vincamine resinates, which process comprises reacting an acid addition salt of vincamine with an alkali metal salt or alkaline earth metal salt of a sulfonic acid cation exchange resin, in a polar reaction medium.
Claim 3
Dependent Claim 37 words
A process according to claim 1, which comprises the use of an alkali metal salt or alkaline earth metal salt of a sulfonic acid cation exchange resin having a particle size of about 50 to 1000 μm.
Claim 4
Dependent Claim 39 words
A process according to claim 1, wherein an acid addition salt of vincamine is reacted with an alkali metal salt of a sulfonation product of a copolymer of (unsubstituted or substituted) styrene with a small amount of divinyl benzene.
Claim 5
Dependent Claim 32 words
A process according to claim 1, wherein the reaction is carried out in water, a lower alkanol, a lower alkanone or a mixture of these solvents with each other and/or with water.
Claim 6
Dependent Claim 26 words
A process according to claim 1, wherein the acid addition salt of vincamine is a mineral acid salt or a salt with an organic sulfonic acid.
Claim 7
Dependent Claim 19 words
A process according to claim 1, wherein the acid addition salt of vincamine is vincamine methanesulfonate or vincamine hydrochloride.
Claim 8
Dependent Claim 59 words
A prolonged action and stable vincamine preparation consisting of vincamine resinate which is bound with a saturation of 10 to 40% on a sulfonic acid cation exchange resin as prepared by the process of claim 1, the remaining sulfonic acid anions of which are substantially saturated by alkali metal or alkaline earth metal ions and an inert pharmaceutical carrier.
Claim 9
Dependent Claim 29 words
A vincamine preparation according to claim 7, in which vincamine is bound on a sulfonic acid cation exchange resin having a particle size of about 50 to 1000 μm.
Claim 10
Dependent Claim 31 words
A vincamine preparation according to claim 7, in which vincamine is bound on a sulfonation product of a copolymer of unsubstituted or substituted styrene with a small amount of divinyl benzene.
Claim 11
Dependent Claim 8 words
A vincamine resinate obtained according to claim 1.
Claim 12
Dependent Claim 10 words
A vincamine resinate obtained according to claims 1 or 2.
Claim 13
Dependent Claim 16 words
A vincamine resinate obtained according to any one of claims 1, 2, 3, 4 or 5.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-01-17 1986-07-19 1987-01-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-01-17 1990-07-19 1991-01-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-01-17 1994-07-19 1995-01-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag